Search

Bryen A Jordan

from New York, NY
Age ~51

Bryen Jordan Phones & Addresses

  • 555 Main St APT 705, New York, NY 10044
  • Troy, NY
  • Washington, DC

Work

Company: Albert einstein college of medicine Feb 2008 Position: Assistant professor

Education

Degree: Ph.D. School / High School: NYU School of Medicine 1996 to 2000 Specialities: Pharmacology

Skills

Molecular Biology • Cell Biology • Cell Culture • Neuroscience • Biochemistry • Science • Fluorescence Microscopy • Western Blotting • Animal Models • Confocal Microscopy • Immunohistochemistry • Cell

Languages

English • Spanish • Serbian • Italian

Interests

Science and Technology

Industries

Research

Resumes

Resumes

Bryen Jordan Photo 1

Associate Professor

View page
Location:
New York, NY
Industry:
Research
Work:
Albert Einstein College of Medicine since Feb 2008
Assistant Professor

NYU School of Medicine 2004 - 2008
Research Assistant Scientist

NYU Langone Medical Center 2001 - 2004
Postdoctoral Fellow
Education:
NYU School of Medicine 1996 - 2000
Ph.D., Pharmacology
Rensselaer Polytechnic Institute 1991 - 1995
BS, Chemical Engineering
Skills:
Molecular Biology
Cell Biology
Cell Culture
Neuroscience
Biochemistry
Science
Fluorescence Microscopy
Western Blotting
Animal Models
Confocal Microscopy
Immunohistochemistry
Cell
Interests:
Science and Technology
Languages:
English
Spanish
Serbian
Italian

Publications

Us Patents

Heterodimeric Opioid G-Protein Coupled Receptors

View page
US Patent:
6855807, Feb 15, 2005
Filed:
Jun 15, 2000
Appl. No.:
10/018200
Inventors:
Lakshmi Arehole Devi - New Rochelle NY, US
Bryen Alexander Jordan - New York NY, US
Assignee:
New York University - New York NY
International Classification:
C07K001/00
C07K014/00
C12N015/74
G01N033/53
C12P021/06
US Classification:
530350, 435 72, 4352523, 435325, 435471, 435 691
Abstract:
Opioid receptors form functional heterodimers with each other and with other G-protein coupled receptors, such as dopamine receptors, adrenergic receptors, or chemokine receptors. These receptors can be exploited for high throughput screening of compounds to identify heterodimer opioid receptor modulators (agonists and antagonists). The invention also relates to identification of novel heterodimer receptor ligands and synergistic compositions, which can provide strategies for analgesia, narcotic addiction, hypertension, HIV infection, and immune system function.
Bryen A Jordan from New York, NY, age ~51 Get Report